Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptides

Journal of Interferon and Cytokine Research

Volumn 20, Issue 4, 2000, Pages 391-401

  Lee, Tom V ^a   Kim, Dong Kyu ^a   Peoples, George E ^a,b   Castilleja, Agapito ^a   Murray, James L ^a   Gershenson, David M ^a   Ioannides, Constantin G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; B7 ANTIGEN; CD28 ANTIGEN; GAMMA INTERFERON; HLA A2 ANTIGEN; INDUCIBLE PROTEIN IP 10; INTERLEUKIN 12; PEPTIDE E75; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIGEN PRESENTING CELL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; T LYMPHOCYTE;

BREAST NEOPLASMS; CD40 LIGAND; CELL ADHESION; CHEMOKINES, CXC; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; KINETICS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; PEPTIDE FRAGMENTS; PLASTICS; RECEPTOR, ERBB-2;

EID: 0034114368     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312333     Document Type: Article

References (41)

1. + T cells during the elicitation of contact hypersensitivity. J. Invest. Dermatol. 107, 360-366.
2. 2. Ward, S.G., Bacon, K., and Westwick, J. (1998). Chemokines and T lymphocytes: More than an attraction. Immunity, 9: 1-11, 1998.
3. + myelin peptide-specific T cells: importance of IFN-inducible protein 10. J. Immunol. 160, 444-448.
4. 4. Sallusto, F., Lenig, D., Mackay, C.R., and Lanzavecchia, A. (1998). Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes . J. Exp. Med. 187, 875-883.
5. 5. Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M., and Hamilton, T.A. (1998). The CXC chemokines IP-10 and MIG are necessary for IL-12-mediated regression of the mouse RENCA tumor. J. Immunol. 161, 927-932.
6. 6. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C, Taub, D. T., Iannettoni, M. D., Whyte, R. L, and Streiter, R. M. (1996). Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor than inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184, 981-992.
7. 7. Luster, A.D., Greenberg, S. M., and Leder, P. (1995). The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182, 219-231.
8. 8. Dias, S., Thomas, H., and Balkwill, F. (1998). Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model. Int. J. Cancer 72, 151-157.
9. 9. Sgadari, C., Angiolillo, A.L., and Tosato, G. (1996). Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87, 3877-3882.
10. 10. Ohmori, Y., Schreiber, R.D., and Hamilton, T.A. (1997). Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J. Biol. Chem. 272, 14899-14907.
11. 11. Luster, A.D., and Ravetch, J.V. (1987). Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site. Mol. Cell. Biol. 7, 3723-3731.
12. 12. Tomura, K., and Narumi, S. (1999). Differential induction of interferon (IFN)-inducible protein 10 following differentiation of a monoctye, macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and kappaB sites. Int. J. Mol. Med. 3, 477-484.
13. 13. Kopydlowski, K.M., Salkowski, C. A., Cody, M.J., Van Rooijen, N., Major, J., Hamilton, T. A., and Vogel, S. N. (1999). Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J. Immunol. 163, 1537-1544.
14. 14. Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A.E., Hunter, C. A., Fox, J. C., Trinchieri, G., and Lee, W. M. F. (1998). Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441-1452.
15. 15. Coughlin, C. M., Salhany, K. E., Gee, M. S., Latemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysock, M., Kim, J. E., Liu, L., Liao, F., Farber, J. M., Pestka, S., Trinchieri, G., and Lee, W. M. (1998). Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity 9, 25-34.
16. + T lymphocytes. J. Immunol. 160, 3642-3647.
17. 17. Koblish, H. K., Hunter, C. A., Wysocka, M., Trinchieri, G., and Lee, W.M.F. (1998). Immune suppression by recombinant interleukin (rIL)-12 involves interferon γ induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. J. Exp. Med. 188, 1603-1610.
18. 18. Luster, A. D., and Leder, P. (1993). IP-10, a C-X-C-chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178, 1057-1065.
19. + T cells. J. Immunol. 158, 3046-3053.
20. 20. Bradley, L. M., Asensio, V. C., Schioetz, L. K., Harbertson, J., Krahl, T., Patstone, G., Woolf, N., Campbell, I. L., and Sarvetnick, N. (1999). Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162, 2511-2520.
21. 21. Fisk, B., Blevins, T.L., Wharton, J.T., and Ioannides, G.G. (1995). Identification of an immunodominant peptide of HER-2/neu proto-oncogene recognized by ovarian tumor-specific cyto-toxic T lymphocyte lines. J. Exp. Med. 181, 2109-2117.
22. 22. Hudson, J.M., Castilleja, A., Murray, J.L., Honda, T., Kudelka, A., Singletary, E., Wharton, J. T., and Ioannides, C. G. (1998). Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer. J. Interferon Cytokine Res. 18, 529-536.
23. 23. Rongcun, Y., Salazar-Onfray, F., Charo, J., Malmberg, K. J., Evrin, K., Maes, H., Kono, K., Hising, C., Petersson, M., Larsson, O., Lan, L., Appella, E., Sette, A., Celis, E., and Kiessling, R. (1999). Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas. J. Immunol. 163, 1037-1044.
24. 24. Tuttle, T.M., Anderson, B.W., Thompson, W.E., Lee, J.E., Grabstein, K.H., Sahin, A., Wharton, J.T., Ioannides, C.G., and Murray, J.E. (1998). Proliferative and cytokine responses to MHC-class II associated HER-2 peptides in breast cancer patients. Clin. Cancer Res. 4, 2015-2024.
25. 25. Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-α. J. Med. Exp. 179, 1109-1118.
26. 26. Dekruyff, R.H., Gieni, R.S., and Umetsu, D.T. (1997). Antigen-driven but not lipopolysaccharid e-driven IL-12 production in macrophages requires triggering of CD40. J. Immunol. 158, 359-366.
27. 27. McDyer, J. F., Goletz, T. J., Thomas, E., June, C. H., and Seder, R. A. (1998). CD40 ligand/CD40 stimulation regulates the production of IFN-γ from human peripheral blood mononu-clear cells in an IL-12 and/or CD28-dependent manner. J. Immunol. 160, 1701-1707.
28. 28. Gately, M. K., Renzetti, L. M., Magram, J., Stern, A., Adorini, L., Gubler, U., and Presky, D. H. (1998). The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495-521.
29. 29. Jaiswal, A., I., Dubey, C., Swain, S. L., and Croft, M. (1995). Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Int. Immunol. 8, 275-285.
30. 30. Peng, X., Remacle, J. E., Kasran, A., Huylebroeck, D., and Cueppens, J.L. (1998). IL-12 up-regulates CD40 ligand (CD154) expression on human T cells. J. Immunol. 160, 1166-1172.
31. 31. Ohmori, Y., and Hamilton, T.A. (1995). The intereferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J. Immunol. 154, 5235-5244.
32. 32. Cheng, G., Nazar, A., Shin, H.S., Vanguri, P., and Shin, M.L. (1998). IP-10 gene transcription by virus in astrocytes requires cooperation of ISRE with adjacent κB site but not IRF-1 or viral transcription. J. Interferon Cyokine Res. 18, 987-997.
33. 33. Xia, Y., Pauza, M. E., Feng, L., and Lø, D. (1997). RelB regulation of chemokine expression modulates local inflammation. Am. J. Pathol. 151, 375-387.
34. 34. Wong, M., and Fish, E. N. (1998). RANTES and MIP-1 activate Stats in T cells. J. Biol. Chem. 273, 309-314.
35. 35. Gangur, V., Simons, F. E. R., and Hayglass, K. T. (1998). Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-γ over IL-4 responses. FASEB J. 12, 705-713.
36. + human peripheral blood lymphocytes and potent sources of macrophage inflammatory protein 1 α, interleukin-8 and RANTES. Eur. J. Immunol. 25, 751-756.
37. 37. Herold, K. C., Lu, J., Rulifson, I., Vezys, V., Taub, D., Grusby, M. J., and Bluestone, J. A. (1997). Regulation of C-C chemokine production by murine T cells by CD28/B7 co-stimulation. J. Immunol. 159, 4150-4153.
38. 38. Weng, Y., Siciliano, S. J., Waldburger, K. E., Sirotina-Meisher, A., Staruch, M. J., Daugherty, B. L., Gould, S. L., Springer, M. S., and Demartino, J. A. (1998). Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Biol. Chem. 273, 18288-18291.
39. 39. Sallusto, F., and Lanzavecchia, A. (1999). Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189, 611-614.
40. 40. De Saint-Vis, B., Fugier-Vivier, I., Massacrier, C., Gaillard, C., Vanbervliet, B., Ait-Yahia, S., Banchereau, J., Liu, Y.-J., Lebecque, S., and Caux, C. (1998). The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160, 1666-1676.
41. + lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood 86, 651-658.